Cargando…

Understanding tolerance to cell wall–active antibiotics

Antibiotic tolerance—the ability of bacteria to survive for an extended time in the presence of bactericidal antibiotics—is an understudied contributor to antibiotic treatment failure. Herein, I review the manifestations, mechanisms, and clinical relevance of tolerance to cell wall–active (CWA) anti...

Descripción completa

Detalles Bibliográficos
Autor principal: Dörr, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359209/
https://www.ncbi.nlm.nih.gov/pubmed/33274447
http://dx.doi.org/10.1111/nyas.14541
_version_ 1783737497786777600
author Dörr, Tobias
author_facet Dörr, Tobias
author_sort Dörr, Tobias
collection PubMed
description Antibiotic tolerance—the ability of bacteria to survive for an extended time in the presence of bactericidal antibiotics—is an understudied contributor to antibiotic treatment failure. Herein, I review the manifestations, mechanisms, and clinical relevance of tolerance to cell wall–active (CWA) antibiotics, one of the most important groups of antibiotics at the forefront of clinical use. I discuss definitions of tolerance and assays for tolerance detection, comprehensively discuss the mechanism of action of β‐lactams and other CWA antibiotics, and then provide an overview of how cells mitigate the potentially lethal effects of CWA antibiotic–induced cell damage to become tolerant. Lastly, I discuss evidence for a role of CWA antibiotic tolerance in clinical antibiotic treatment failure.
format Online
Article
Text
id pubmed-8359209
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83592092021-08-17 Understanding tolerance to cell wall–active antibiotics Dörr, Tobias Ann N Y Acad Sci Reviews Antibiotic tolerance—the ability of bacteria to survive for an extended time in the presence of bactericidal antibiotics—is an understudied contributor to antibiotic treatment failure. Herein, I review the manifestations, mechanisms, and clinical relevance of tolerance to cell wall–active (CWA) antibiotics, one of the most important groups of antibiotics at the forefront of clinical use. I discuss definitions of tolerance and assays for tolerance detection, comprehensively discuss the mechanism of action of β‐lactams and other CWA antibiotics, and then provide an overview of how cells mitigate the potentially lethal effects of CWA antibiotic–induced cell damage to become tolerant. Lastly, I discuss evidence for a role of CWA antibiotic tolerance in clinical antibiotic treatment failure. John Wiley and Sons Inc. 2020-12-03 2021-07 /pmc/articles/PMC8359209/ /pubmed/33274447 http://dx.doi.org/10.1111/nyas.14541 Text en © 2020 The Authors. Annals of the New York Academy of Sciences published by Wiley Periodicals LLC on behalf of New York Academy of Sciences https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Dörr, Tobias
Understanding tolerance to cell wall–active antibiotics
title Understanding tolerance to cell wall–active antibiotics
title_full Understanding tolerance to cell wall–active antibiotics
title_fullStr Understanding tolerance to cell wall–active antibiotics
title_full_unstemmed Understanding tolerance to cell wall–active antibiotics
title_short Understanding tolerance to cell wall–active antibiotics
title_sort understanding tolerance to cell wall–active antibiotics
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359209/
https://www.ncbi.nlm.nih.gov/pubmed/33274447
http://dx.doi.org/10.1111/nyas.14541
work_keys_str_mv AT dorrtobias understandingtolerancetocellwallactiveantibiotics